Self help book + telephone support
OtherSelf-help book based upon principles of Acceptance and Commitment Therapy
NCT Number: NCT02565056
The purpose of this study is to assess the feasibility of conducting a trial to evaluate a self-help treatment for depression in people with end-stage renal disease.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Shipley Dialysis Unit, Ilkeston Community Hospital, Ilkeston, Derbyshire, United Kingdom
Chronic Kidney Disease (CKD) is a long-term condition in which the function of the kidneys - to filter out waste products from the blood - slowly declines. When renal function becomes sufficiently low it is described as End Stage Renal Disease (ESRD) and renal replacement therapy (RRT) is likely to be needed to prolong life. The most common type of RRT is haemodialysis, in which the patient's blood is filtered through a machine.
It is estimated that depression is experienced by 20-40% of people with ESRD. Depression not only affects the quality of life of individuals with ESRD but is also associated with higher rates of hospitalisation and poorer physical health outcomes.
Acceptance and Commitment Therapy (ACT) has been found to be an effective treatment for depression and has been used successfully as a self-help treatment. However, no study has examined the effectiveness of an ACT self-help treatment for depression in ESRD. This study aims to assess the feasibility of conducting such a study and will look at suitability of recruitment, assessment methods and the acceptability of the self-help treatment, as well as helping to calculate the number of people needed for a definitive study.
Haemodialysis patients receiving dialysis through an NHS renal service will be invited to participate. To participate they will be consenting, over 18 years of age and experiencing depressive symptoms at a clinical level. Those eligible will be randomly assigned into one of two conditions; a control condition receiving treatment as usual (TAU), and an intervention condition receiving TAU alongside an ACT self-help manual with weekly telephone support. The manual will be completed over six weeks. Both groups will be asked to complete questionnaires prior to intervention and 2 and 4 months post-intervention. Participants from each condition will be asked to participate in interviews to explore their experiences of taking part.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Self-help book based upon principles of Acceptance and Commitment Therapy
Time frame: Baseline; 2 months; 4 months
Validated self-report questionnaire assessing symptoms of depression
Time frame: Baseline; 2 months; 4 months
Validated self-report questionnaire assessing health-related quality of life
Time frame: Baseline; 2 months; 4 months
Validated self-report questionnaire assessing psychological flexibility
Time frame: Baseline; 2 months; 4 months
Validated self-report questionnaire assessing the extent to which individuals live consistently with their identified values
University of Lincoln
Other
Acceptance and Commitment Therapy Self-help Intervention for Depression in Haemodialysis Patients: A Feasibility Randomised Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05571007
Anxiety Disorders, Behavior
Purwokerto, Central Java, Indonesia
View Trial DetailsNCT07518628
Behavior, Chronic Disease
Nicosia, Cyprus
View Trial DetailsNCT05154773
Chronic Disease, Chronic Kidney Diseases
Buffalo, New York, United States
View Trial DetailsNCT04466865
Behavior, Chronic Disease
Denver, Colorado, United States
View Trial Details